Titan Medical Inc (TMD.TO)
0.055
0.00 (0.00%)
CAD |
TSX |
May 27, 10:09
Titan Medical Enterprise Value: -1.454M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | -1.454M |
| May 23, 2024 | -2.025M |
| May 22, 2024 | -1.454M |
| May 21, 2024 | -1.454M |
| May 17, 2024 | -2.025M |
| May 16, 2024 | -1.454M |
| May 15, 2024 | -1.454M |
| May 14, 2024 | -1.454M |
| May 13, 2024 | -1.454M |
| May 10, 2024 | -0.8843M |
| May 09, 2024 | -0.8843M |
| May 08, 2024 | -1.454M |
| May 07, 2024 | -1.454M |
| May 06, 2024 | -1.454M |
| May 03, 2024 | -2.025M |
| May 02, 2024 | -0.8843M |
| May 01, 2024 | -0.8843M |
| April 30, 2024 | -0.8843M |
| April 29, 2024 | -0.8843M |
| April 26, 2024 | -1.454M |
| April 25, 2024 | -1.454M |
| April 24, 2024 | -1.454M |
| April 23, 2024 | -0.8843M |
| April 22, 2024 | -0.8843M |
| April 19, 2024 | -1.454M |
| Date | Value |
|---|---|
| April 18, 2024 | -0.8843M |
| April 17, 2024 | -0.8843M |
| April 16, 2024 | 0.2561M |
| April 15, 2024 | -0.3141M |
| April 12, 2024 | -0.3141M |
| April 11, 2024 | -0.3141M |
| April 10, 2024 | 0.2561M |
| April 09, 2024 | 0.2561M |
| April 08, 2024 | 0.8263M |
| April 05, 2024 | 0.2561M |
| April 04, 2024 | 0.2561M |
| April 03, 2024 | 0.2561M |
| April 02, 2024 | -0.3141M |
| April 01, 2024 | -0.3141M |
| March 28, 2024 | -1.450M |
| March 27, 2024 | -1.450M |
| March 26, 2024 | -1.450M |
| March 25, 2024 | -2.02M |
| March 22, 2024 | -1.450M |
| March 21, 2024 | -1.450M |
| March 20, 2024 | -0.3094M |
| March 19, 2024 | -0.3094M |
| March 18, 2024 | 0.2608M |
| March 15, 2024 | 0.2608M |
| March 14, 2024 | -0.3094M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.059M
Minimum
Nov 30 2023
341.41M
Maximum
Feb 09 2021
62.62M
Average
42.25M
Median
Dec 02 2021
Enterprise Value Benchmarks
| Biocure Technology Inc | 1.448M |
| Core One Labs Inc | 8.808M |
| Nova Mentis Life Science Corp | 2.183M |
| Nanosphere Health Sciences Inc | 0.2959M |
| Lobe Sciences Ltd | 2.834M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.088M |
| Total Expenses (Quarterly) | 1.132M |
| EPS Diluted (Quarterly) | -0.0135 |
| Earnings Yield | 122.5% |
| Operating Earnings Yield | 177.3% |
| Normalized Earnings Yield | 174.01 |